EUVIMEDEUVIMED entdecken
Open Access

Sphingolipid biosynthetic inhibitor L-Cycloserine prevents oxidative-stress-mediated death in an in vitro model of photoreceptor-derived 661W cells

Faiza Tahia, Sandip K Basu, Amanda Prislovsky, Koushik Mondal, Dejian Ma, Harry Kochat, Kennard Brown, Daniel J Stephenson, Charles E Chalfant, Nawajes Mandal

Experimental Eye Research · 2024

DOI: 10.1016/j.exer.2024.109852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Eye Research, 2024. Verfasst von Faiza Tahia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, 38163, USA; Department of Ophthalmology, Universit…. Hauptthemen laut MEDLINE: Oxidative Stress, Cycloserine, Ceramides, Sphingolipids. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, BLRD VA, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress plays a pivotal role in the pathogenesis of several neurodegenerative diseases. Retinal degeneration causes irreversible death of photoreceptor cells, ultimately leading to vision loss. Under oxidative stress, the synthesis of bioactive sphingolipid ceramide increases, triggering apoptosis in photoreceptor cells and leading to their death. This study investigates the effect of L-Cycloserine, a small molecule inhibitor of ceramide biosynthesis, on sphingolipid metabolism and the protection of photoreceptor-derived 661W cells from oxidative stress. The results demonstrate that treatment with L-Cycloserine, an inhibitor of Serine palmitoyl transferase (SPT), markedly decreases bioactive ceramide and associated sphingolipids in 661W cells. A nontoxic dose of L-Cycloserine can provide substantial protection of 661W cells against H2O2-induced oxidative stress by reversing the increase in ceramide level observed under oxidative stress conditions. Analysis of various antioxidant, apoptotic and sphingolipid pathway genes and proteins also confirms the ability of L-Cycloserine to modulate these pathways. Our findings elucidate the generation of sphingolipid mediators of cell death in retinal cells under oxidative stress and the potential of L-Cycloserine as a therapeutic candidate for targeting ceramide-induced degenerative diseases by inhibiting SPT. The promising therapeutic prospect identified in our findings lays the groundwork for further validation in in-vivo and preclinical models of retinal degeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressCycloserineCeramidesSphingolipidsApoptosisAnimalsMicePhotoreceptor Cells, VertebrateSerine C-PalmitoyltransferaseHydrogen PeroxideCell LineRetinal DegenerationBlotting, WesternEnzyme InhibitorsCell Survival

Stichwörter der Autor:innen

Ceramide biosynthesisL-CycloserineOxidative stressPhotoreceptorsRetinaRetinal cell deathSerine palmitoyl transferase (SPT)SphingolipidsTherapeutic intervention

Substanzen

CycloserineCeramidesSphingolipidsSerine C-PalmitoyltransferaseHydrogen PeroxideEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, 38163, USA; Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
  • Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
  • Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, 38163, USA; Memphis VA Medical Center, Memphis, TN, 38104, USA.
  • Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
  • Plough Center for Sterile Drug Delivery Solutions, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
  • Office of Executive Vice Chancellor and Chief Operations Officer, University of Tennessee Health Science Center, Memphis, TN, 38163, USA.

Förderung

  • NEI NIH HHS
  • BLRD VA
  • NIDDK NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIAID NIH HHS
  • National Institutes of Health
  • US Department of Defense

Zitieren

APA

Tahia, F., Basu, S. K., Prislovsky, A., Mondal, K., Ma, D., Kochat, H., Brown, K., Stephenson, D. J., Chalfant, C. E., & Mandal, N. (2024). Sphingolipid biosynthetic inhibitor L-Cycloserine prevents oxidative-stress-mediated death in an in vitro model of photoreceptor-derived 661W cells. Experimental Eye Research. https://doi.org/10.1016/j.exer.2024.109852

Vancouver

Tahia F, Basu SK, Prislovsky A, Mondal K, Ma D, Kochat H, et al. Sphingolipid biosynthetic inhibitor L-Cycloserine prevents oxidative-stress-mediated death in an in vitro model of photoreceptor-derived 661W cells. Experimental Eye Research. 2024. doi:10.1016/j.exer.2024.109852

BibTeX
@article{Tahia2024,
  author = {Tahia, Faiza and Basu, Sandip K and Prislovsky, Amanda and Mondal, Koushik and Ma, Dejian and Kochat, Harry and Brown, Kennard and Stephenson, Daniel J and Chalfant, Charles E and Mandal, Nawajes},
  title = {Sphingolipid biosynthetic inhibitor L-Cycloserine prevents oxidative-stress-mediated death in an in vitro model of photoreceptor-derived 661W cells},
  journal = {Experimental Eye Research},
  year = {2024},
  doi = {10.1016/j.exer.2024.109852}
}
Kostenlos starten →